TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

BACKGROUND: Currently definitive 5-fluorouracil (5-FU)/cisplatin (CDDP) -based chemotherapy is recognized as one of the most promising treatments for esophageal cancer. A series of studies performed found genetic polymorphisms and the plasma concentration of 5-FU to be predictive of acute severe tox...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kuwahara, Akiko, Yamamori, Motohiro, Fujita, Megumi, Okuno, Tatsuya, Tamura, Takao, Kadoyama, Kaori, Okamura, Noboru, Nakamura, Tsutomu, Sakaeda, Toshiyuki
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2010
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2915971/
https://ncbi.nlm.nih.gov/pubmed/20646319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-29-100
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים